Do GLP-1s Work for Depression—or Is It Metabolism?

About this episode

The episode discusses the relationship between GLP-1 medications and mental health, highlighting recent research findings and their implications.

GLP-1 medications like semaglutide have been widely discussed as breakthrough treatments for weight loss and metabolic health. But a large new study published in The Lancet Psychiatry is shifting the conversation toward something deeper: the connection between metabolic health and mental health. In this video, Dr. Bret Scher breaks down what the research actually shows, and just as importantly, what it doesn’t. The study analyzed health records from over 95,000 individuals with type 2 diabetes and depression or anxiety. Those taking GLP-1 medications showed a lower risk of severe psychiatric outcomes, including hospitalization and self-harm, compared to other diabetes treatments. But here’s the nuance: This wasn’t an intervention trial, and it didn’t show that GLP-1s treat depression or lead to remission. Instead, it showed less worsening of mental health over time. This video explores: What “less worsening” really means in mental health research Why metabolic health and brain health are closely connected The limitations of large observational studies How GLP-1s might fit into a broader metabolic approach to mental health The emerging role of ketogenic therapy and other metabolic…

People in this episode

Host: Dr. Bret Scher

Topics covered

• GLP-1 medications
• metabolic health
• mental health
• depression
• type 2 diabetes
• observational studies

Keywords

• GLP-1
• depression
• metabolic health
• mental health
• semaglutide
• type 2 diabetes
• observational studies
• ketogenic therapy

Mentioned in this episode

Organizations: The Lancet Psychiatry, Coalition for Metabolic Health

Products: GLP-1 medications, semaglutide

More episodes of Metabolic Mind

• BITESIZE: The New Protein Guidelines Reignited the Plant vs. Animal Debate · June 12, 2026 · 7 min
• BITESIZE: Omega-3 Supplements and Cognitive Decline? Here’s the Full Story · June 10, 2026 · 8 min
• Whole-Person Psychiatry Is Changing Mental Health Care—with Meru Health’s Kristian Ranta · June 8, 2026 · 31 min
• New Study from 25-Year Eating Disorder Expert · June 5, 2026 · 36 min
• First Keto Trial for Anorexia Nervosa: 72% Showed Recovery · June 3, 2026 · 4 min
• BITESIZE: New Study: Why Did This Drug Lower Cholesterol But Not Heart Plaque? · June 1, 2026 · 4 min